vidarabine phosphate has been researched along with 2-fluoroadenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennetts, E; Both, GW; Madden, V; Martiniello-Wilks, R; Russell, PJ; Smith, K; Voeks, D | 1 |
| Both, GW; Cameron, F; Cooke-Yarborough, C; Coulston, N; Ho, T; Lockett, TJ; Martiniello-Wilks, R; Moghaddam, M; Molloy, PL; Russell, PJ; Shaw, JM; Smith, IK; Wang, XY; Webster, LK | 1 |
2 other study(ies) available for vidarabine phosphate and 2-fluoroadenine
| Article | Year |
|---|---|
Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.
Topics: Adenine; Animals; Avian Sarcoma Viruses; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Male; Mastadenovirus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms, Experimental; Prodrugs; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Transduction, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured; Vidarabine Phosphate | 2002 |
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Replication; Drug Evaluation, Preclinical; Genetic Therapy; Genetic Vectors; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prodrugs; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Vidarabine Phosphate | 2004 |